PUTNAM INVESTMENTS LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,464,645
-60.7%
20,332
-62.8%
0.00%
-55.6%
Q2 2023$6,266,534
-45.0%
54,720
-33.8%
0.01%
-50.0%
Q1 2023$11,391,650
-18.1%
82,650
-23.0%
0.02%
-25.0%
Q4 2022$13,906,266
+17.2%
107,318
-0.0%
0.02%
+4.3%
Q3 2022$11,864,000
+179.6%
107,325
+89.6%
0.02%
+187.5%
Q2 2022$4,243,000
-35.5%
56,600
+46.8%
0.01%
-33.3%
Q4 2020$6,574,000
+18.0%
38,560
-2.8%
0.01%
+9.1%
Q3 2020$5,573,000
-49.4%
39,689
-42.2%
0.01%
-52.2%
Q2 2020$11,007,000
-5.8%
68,646
-42.6%
0.02%
-25.8%
Q1 2020$11,689,000
+15.7%
119,500
+52.6%
0.03%
+47.6%
Q4 2019$10,104,000
+125.9%
78,300
+166.0%
0.02%
+110.0%
Q2 2019$4,473,000
+23.5%
29,438
-3.1%
0.01%
+25.0%
Q1 2019$3,622,000
+0.1%
30,391
-8.4%
0.01%
-20.0%
Q4 2018$3,619,000
-32.4%
33,1600.0%0.01%
-16.7%
Q3 2018$5,355,000
+36.5%
33,160
+11.7%
0.01%
+200.0%
Q2 2018$3,924,000
+122.2%
29,696
+24.6%
0.00%0.0%
Q1 2018$1,766,000
-30.1%
23,832
-47.6%
0.00%
+33.3%
Q4 2017$2,528,000
+220.8%
45,464
+161.7%
0.00%
+50.0%
Q3 2017$788,00017,3740.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders